![Andre J. Gudger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andre J. Gudger
Direktör/Styrelseledamot på
CytoDel LLC
Profil
Andre J.
Gudger is currently the Director at CytoDel LLC.
Previously, he was the Chairman & Chief Executive Officer at Solvern Innovations, Inc. from 2003 to 2009.
He obtained an undergraduate degree from the University of Maryland and an MBA from The University of North Carolina at Charlotte.
Aktiva positioner av Andre J. Gudger
| Företag | Position | Start |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Andre J. Gudger
| Företag | Position | Slut |
|---|---|---|
Solvern Innovations, Inc.
 Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Ordförande | 2009-01-01 |
Andre J. Gudgers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
9
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvern Innovations, Inc.
Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Technology Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
